Last updated: July 2026
PrEP for Women: What's Different and What Works
Women account for about one in five new HIV diagnoses in the US, yet PrEP awareness and uptake among women lag far behind men. The medicine works — but several things about PrEP genuinely are different for women, and knowing them matters for protection.
The short version
- PrEP is effective for women — but daily adherence matters more than it does for men.
- Two options are approved for vaginal exposure: Truvada/generic and the Apretude injection. Descovy is not.
- On-demand 2-1-1 dosing does not protect vaginal exposure — it's a strategy for men only.
- PrEP is compatible with hormonal birth control and is an option during pregnancy and breastfeeding when risk is present.
Why daily matters more for women
Tenofovir concentrates less efficiently in vaginal tissue than in rectal tissue — drug levels build slower and sit lower. Practically: full protection takes about 21 days of daily dosing to establish (versus ~7 for anal exposure), and the "forgiveness" men get from occasional missed doses doesn't transfer. For women, daily really means daily. If that's a poor fit for your life, that's precisely the problem the every-two-months injection solves — and its major trial in women (HPTN 084) showed it dramatically outperformed daily pills.
Your two evidence-backed options
| Daily oral TDF-FTC | Apretude injection | |
|---|---|---|
| Schedule | One pill every day | Shot every 2 months |
| Protection at full adherence | High (with strict daily use) | Very high — superior in trials |
| Cost | Generic, often $0 (guide) | Usually covered; assistance available |
| Consider if | Routine pill-taking suits you | Daily dosing is unrealistic, or maximum protection wanted |
Why not Descovy? Its approval trial enrolled no cisgender women, so it isn't approved for receptive vaginal exposure — not proven unsafe, just unproven. Details here.
Pregnancy, contraception, and hormones
PrEP doesn't reduce contraceptive effectiveness, and hormonal birth control doesn't reduce PrEP's. During conception attempts with a partner living with HIV, during pregnancy, and while breastfeeding, oral TDF-FTC has substantial reassuring safety data and is recommended when HIV risk is present — an important conversation to have openly with your prescriber rather than stopping protection quietly.
Getting PrEP without the awkwardness
Many women report their regular doctor never raised PrEP, or seemed surprised they asked. You don't need to justify your risk profile to anyone: interest is indication enough to have the conversation. Telehealth removes most of the friction — a private consult, mailed labs or a quick draw, and pharmacy delivery.
See your options — pick your state
Where you live determines who can prescribe for you via telehealth.
Good news: our reviewing clinical team at The Practice serves your state directly by telehealth.
Book a telehealth visit with The PracticeOr call (904) 877-1100
The Practice doesn't prescribe in your state yet. These established telehealth services do:
MISTR — free PrEP & DoxyPEP online, most states Wisp — sexual-health telehealth & pharmacy CallonDoc — same-day online prescriptions